nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.0443	1	CbGdCrCtD
Mupirocin—Wound infection—Mycophenolic acid—systemic scleroderma	0.0433	0.0538	CcSEcCtD
Mupirocin—IARS—connective tissue—systemic scleroderma	0.0312	0.207	CbGeAlD
Mupirocin—Sensitisation—Mometasone—systemic scleroderma	0.0288	0.0358	CcSEcCtD
Mupirocin—IARS—smooth muscle tissue—systemic scleroderma	0.0286	0.189	CbGeAlD
Mupirocin—IARS—skin of body—systemic scleroderma	0.0282	0.187	CbGeAlD
Mupirocin—Furunculosis—Mometasone—systemic scleroderma	0.0242	0.0301	CcSEcCtD
Mupirocin—IARS—digestive system—systemic scleroderma	0.0226	0.15	CbGeAlD
Mupirocin—IARS—tendon—systemic scleroderma	0.0215	0.142	CbGeAlD
Mupirocin—Furuncle—Mometasone—systemic scleroderma	0.021	0.0261	CcSEcCtD
Mupirocin—IARS—lung—systemic scleroderma	0.0188	0.125	CbGeAlD
Mupirocin—Furunculosis—Mycophenolate mofetil—systemic scleroderma	0.0132	0.0164	CcSEcCtD
Mupirocin—Stinging—Mometasone—systemic scleroderma	0.0127	0.0158	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Mycophenolate mofetil—systemic scleroderma	0.0121	0.0151	CcSEcCtD
Mupirocin—Furuncle—Mycophenolate mofetil—systemic scleroderma	0.0114	0.0142	CcSEcCtD
Mupirocin—Dermatitis contact—Mometasone—systemic scleroderma	0.0102	0.0126	CcSEcCtD
Mupirocin—Ear pain—Pentoxifylline—systemic scleroderma	0.0101	0.0126	CcSEcCtD
Mupirocin—Swelling—Pentoxifylline—systemic scleroderma	0.00981	0.0122	CcSEcCtD
Mupirocin—Blepharitis—Mycophenolate mofetil—systemic scleroderma	0.00911	0.0113	CcSEcCtD
Mupirocin—Ear pain—Mometasone—systemic scleroderma	0.00875	0.0109	CcSEcCtD
Mupirocin—Cellulitis—Mycophenolic acid—systemic scleroderma	0.00781	0.0097	CcSEcCtD
Mupirocin—Furunculosis—Methotrexate—systemic scleroderma	0.00747	0.00928	CcSEcCtD
Mupirocin—Dermatitis contact—Leflunomide—systemic scleroderma	0.00736	0.00914	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00695	0.00863	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Methotrexate—systemic scleroderma	0.00688	0.00854	CcSEcCtD
Mupirocin—Mouth ulceration—Leflunomide—systemic scleroderma	0.00673	0.00836	CcSEcCtD
Mupirocin—Furuncle—Methotrexate—systemic scleroderma	0.00647	0.00804	CcSEcCtD
Mupirocin—Mouth ulceration—Mycophenolic acid—systemic scleroderma	0.00642	0.00798	CcSEcCtD
Mupirocin—Epistaxis—Pentoxifylline—systemic scleroderma	0.00629	0.00781	CcSEcCtD
Mupirocin—Cellulitis—Mycophenolate mofetil—systemic scleroderma	0.00616	0.00766	CcSEcCtD
Mupirocin—Ear pain—Mycophenolic acid—systemic scleroderma	0.00604	0.00751	CcSEcCtD
Mupirocin—Haemoglobin—Pentoxifylline—systemic scleroderma	0.00602	0.00747	CcSEcCtD
Mupirocin—Eczema—Leflunomide—systemic scleroderma	0.00601	0.00747	CcSEcCtD
Mupirocin—Haemorrhage—Pentoxifylline—systemic scleroderma	0.00598	0.00744	CcSEcCtD
Mupirocin—Swelling—Mycophenolic acid—systemic scleroderma	0.00584	0.00726	CcSEcCtD
Mupirocin—Epistaxis—Mometasone—systemic scleroderma	0.00543	0.00674	CcSEcCtD
Mupirocin—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00541	0.00672	CcSEcCtD
Mupirocin—Erythema—Pentoxifylline—systemic scleroderma	0.00521	0.00647	CcSEcCtD
Mupirocin—Rhinitis—Mometasone—systemic scleroderma	0.00518	0.00643	CcSEcCtD
Mupirocin—Eczema—Lisinopril—systemic scleroderma	0.00517	0.00642	CcSEcCtD
Mupirocin—Pharyngitis—Mometasone—systemic scleroderma	0.00513	0.00637	CcSEcCtD
Mupirocin—Dysgeusia—Pentoxifylline—systemic scleroderma	0.0051	0.00634	CcSEcCtD
Mupirocin—Mouth ulceration—Mycophenolate mofetil—systemic scleroderma	0.00507	0.0063	CcSEcCtD
Mupirocin—Dry skin—Leflunomide—systemic scleroderma	0.00495	0.00615	CcSEcCtD
Mupirocin—Ear pain—Mycophenolate mofetil—systemic scleroderma	0.00477	0.00592	CcSEcCtD
Mupirocin—Angioedema—Pentoxifylline—systemic scleroderma	0.00476	0.00591	CcSEcCtD
Mupirocin—Immune system disorder—Mometasone—systemic scleroderma	0.00466	0.0058	CcSEcCtD
Mupirocin—Rhinitis—Captopril—systemic scleroderma	0.00455	0.00565	CcSEcCtD
Mupirocin—Pharyngitis—Captopril—systemic scleroderma	0.0045	0.00559	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.0044	0.00547	CcSEcCtD
Mupirocin—Dry mouth—Pentoxifylline—systemic scleroderma	0.00434	0.00539	CcSEcCtD
Mupirocin—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00425	0.00528	CcSEcCtD
Mupirocin—Skin disorder—Pentoxifylline—systemic scleroderma	0.00413	0.00513	CcSEcCtD
Mupirocin—Angioedema—Mometasone—systemic scleroderma	0.00411	0.0051	CcSEcCtD
Mupirocin—Haemoglobin—Azathioprine—systemic scleroderma	0.00398	0.00494	CcSEcCtD
Mupirocin—Haemorrhage—Azathioprine—systemic scleroderma	0.00396	0.00492	CcSEcCtD
Mupirocin—Epistaxis—Leflunomide—systemic scleroderma	0.00393	0.00488	CcSEcCtD
Mupirocin—Cough—Mometasone—systemic scleroderma	0.00392	0.00487	CcSEcCtD
Mupirocin—Dysgeusia—Captopril—systemic scleroderma	0.00387	0.0048	CcSEcCtD
Mupirocin—Haemoglobin—Leflunomide—systemic scleroderma	0.00376	0.00467	CcSEcCtD
Mupirocin—Rhinitis—Leflunomide—systemic scleroderma	0.00375	0.00466	CcSEcCtD
Mupirocin—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00375	0.00466	CcSEcCtD
Mupirocin—Dry mouth—Mometasone—systemic scleroderma	0.00374	0.00465	CcSEcCtD
Mupirocin—Haemorrhage—Leflunomide—systemic scleroderma	0.00374	0.00464	CcSEcCtD
Mupirocin—Pharyngitis—Leflunomide—systemic scleroderma	0.00371	0.00461	CcSEcCtD
Mupirocin—Anaphylactic shock—Mometasone—systemic scleroderma	0.00367	0.00456	CcSEcCtD
Mupirocin—Angioedema—Captopril—systemic scleroderma	0.00361	0.00448	CcSEcCtD
Mupirocin—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00358	0.00445	CcSEcCtD
Mupirocin—Immune system disorder—Azathioprine—systemic scleroderma	0.00358	0.00444	CcSEcCtD
Mupirocin—Rhinitis—Mycophenolic acid—systemic scleroderma	0.00358	0.00444	CcSEcCtD
Mupirocin—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00357	0.00443	CcSEcCtD
Mupirocin—Pharyngitis—Mycophenolic acid—systemic scleroderma	0.00354	0.0044	CcSEcCtD
Mupirocin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00348	0.00432	CcSEcCtD
Mupirocin—Cough—Captopril—systemic scleroderma	0.00345	0.00428	CcSEcCtD
Mupirocin—Urticaria—Pentoxifylline—systemic scleroderma	0.00338	0.0042	CcSEcCtD
Mupirocin—Immune system disorder—Leflunomide—systemic scleroderma	0.00338	0.0042	CcSEcCtD
Mupirocin—Epistaxis—Lisinopril—systemic scleroderma	0.00337	0.00419	CcSEcCtD
Mupirocin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00336	0.00418	CcSEcCtD
Mupirocin—Dry mouth—Captopril—systemic scleroderma	0.00329	0.00408	CcSEcCtD
Mupirocin—Anaphylactic shock—Captopril—systemic scleroderma	0.00322	0.004	CcSEcCtD
Mupirocin—Rhinitis—Lisinopril—systemic scleroderma	0.00322	0.004	CcSEcCtD
Mupirocin—Pharyngitis—Lisinopril—systemic scleroderma	0.00319	0.00396	CcSEcCtD
Mupirocin—Dysgeusia—Leflunomide—systemic scleroderma	0.00319	0.00396	CcSEcCtD
Mupirocin—Pain—Mometasone—systemic scleroderma	0.00314	0.0039	CcSEcCtD
Mupirocin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00313	0.00389	CcSEcCtD
Mupirocin—Pruritus—Pentoxifylline—systemic scleroderma	0.00301	0.00374	CcSEcCtD
Mupirocin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.003	0.00373	CcSEcCtD
Mupirocin—Angioedema—Leflunomide—systemic scleroderma	0.00297	0.00369	CcSEcCtD
Mupirocin—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00296	0.00367	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00291	0.00362	CcSEcCtD
Mupirocin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00291	0.00361	CcSEcCtD
Mupirocin—Abdominal pain—Mometasone—systemic scleroderma	0.0029	0.0036	CcSEcCtD
Mupirocin—Mouth ulceration—Methotrexate—systemic scleroderma	0.00287	0.00357	CcSEcCtD
Mupirocin—Cough—Leflunomide—systemic scleroderma	0.00284	0.00353	CcSEcCtD
Mupirocin—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00283	0.00351	CcSEcCtD
Mupirocin—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00282	0.00351	CcSEcCtD
Mupirocin—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00281	0.0035	CcSEcCtD
Mupirocin—Dizziness—Pentoxifylline—systemic scleroderma	0.00281	0.00349	CcSEcCtD
Mupirocin—Erythema—Lisinopril—systemic scleroderma	0.0028	0.00347	CcSEcCtD
Mupirocin—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.00279	0.00347	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00275	0.00342	CcSEcCtD
Mupirocin—Dysgeusia—Lisinopril—systemic scleroderma	0.00274	0.0034	CcSEcCtD
Mupirocin—Skin disorder—Azathioprine—systemic scleroderma	0.00273	0.00339	CcSEcCtD
Mupirocin—Dry mouth—Leflunomide—systemic scleroderma	0.00271	0.00337	CcSEcCtD
Mupirocin—Cough—Mycophenolic acid—systemic scleroderma	0.00271	0.00337	CcSEcCtD
Mupirocin—Rash—Pentoxifylline—systemic scleroderma	0.00268	0.00333	CcSEcCtD
Mupirocin—Dermatitis—Pentoxifylline—systemic scleroderma	0.00268	0.00333	CcSEcCtD
Mupirocin—Headache—Pentoxifylline—systemic scleroderma	0.00266	0.00331	CcSEcCtD
Mupirocin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00266	0.0033	CcSEcCtD
Mupirocin—Gastrointestinal pain—Captopril—systemic scleroderma	0.00263	0.00327	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00262	0.00326	CcSEcCtD
Mupirocin—Pruritus—Mometasone—systemic scleroderma	0.0026	0.00323	CcSEcCtD
Mupirocin—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00258	0.00321	CcSEcCtD
Mupirocin—Skin disorder—Leflunomide—systemic scleroderma	0.00258	0.00321	CcSEcCtD
Mupirocin—Angioedema—Lisinopril—systemic scleroderma	0.00255	0.00317	CcSEcCtD
Mupirocin—Abdominal pain—Captopril—systemic scleroderma	0.00255	0.00316	CcSEcCtD
Mupirocin—Dry skin—Prednisone—systemic scleroderma	0.00253	0.00314	CcSEcCtD
Mupirocin—Nausea—Pentoxifylline—systemic scleroderma	0.00253	0.00314	CcSEcCtD
Mupirocin—Diarrhoea—Mometasone—systemic scleroderma	0.00251	0.00312	CcSEcCtD
Mupirocin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00246	0.00306	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00244	0.00303	CcSEcCtD
Mupirocin—Cough—Lisinopril—systemic scleroderma	0.00244	0.00303	CcSEcCtD
Mupirocin—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.0024	0.00298	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00236	0.00294	CcSEcCtD
Mupirocin—Dry mouth—Lisinopril—systemic scleroderma	0.00233	0.00289	CcSEcCtD
Mupirocin—Rash—Mometasone—systemic scleroderma	0.00231	0.00287	CcSEcCtD
Mupirocin—Dermatitis—Mometasone—systemic scleroderma	0.00231	0.00287	CcSEcCtD
Mupirocin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.0023	0.00286	CcSEcCtD
Mupirocin—Headache—Mometasone—systemic scleroderma	0.0023	0.00286	CcSEcCtD
Mupirocin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00228	0.00284	CcSEcCtD
Mupirocin—Pruritus—Captopril—systemic scleroderma	0.00228	0.00283	CcSEcCtD
Mupirocin—Pain—Leflunomide—systemic scleroderma	0.00227	0.00282	CcSEcCtD
Mupirocin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00278	CcSEcCtD
Mupirocin—Abdominal pain—Azathioprine—systemic scleroderma	0.00222	0.00276	CcSEcCtD
Mupirocin—Skin disorder—Lisinopril—systemic scleroderma	0.00222	0.00275	CcSEcCtD
Mupirocin—Diarrhoea—Captopril—systemic scleroderma	0.0022	0.00274	CcSEcCtD
Mupirocin—Nausea—Mometasone—systemic scleroderma	0.00218	0.00271	CcSEcCtD
Mupirocin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00217	0.0027	CcSEcCtD
Mupirocin—Pain—Mycophenolic acid—systemic scleroderma	0.00217	0.00269	CcSEcCtD
Mupirocin—Cough—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00266	CcSEcCtD
Mupirocin—Dizziness—Captopril—systemic scleroderma	0.00213	0.00265	CcSEcCtD
Mupirocin—Urticaria—Leflunomide—systemic scleroderma	0.00211	0.00262	CcSEcCtD
Mupirocin—Abdominal pain—Leflunomide—systemic scleroderma	0.0021	0.00261	CcSEcCtD
Mupirocin—Hypersensitivity—Azathioprine—systemic scleroderma	0.00207	0.00257	CcSEcCtD
Mupirocin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00207	0.00257	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00257	CcSEcCtD
Mupirocin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00253	CcSEcCtD
Mupirocin—Rash—Captopril—systemic scleroderma	0.00203	0.00252	CcSEcCtD
Mupirocin—Dermatitis—Captopril—systemic scleroderma	0.00203	0.00252	CcSEcCtD
Mupirocin—Headache—Captopril—systemic scleroderma	0.00202	0.00251	CcSEcCtD
Mupirocin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.002	0.00249	CcSEcCtD
Mupirocin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.002	0.00248	CcSEcCtD
Mupirocin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00196	0.00243	CcSEcCtD
Mupirocin—Pain—Lisinopril—systemic scleroderma	0.00195	0.00242	CcSEcCtD
Mupirocin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00241	CcSEcCtD
Mupirocin—Diarrhoea—Azathioprine—systemic scleroderma	0.00192	0.00239	CcSEcCtD
Mupirocin—Haemoglobin—Prednisone—systemic scleroderma	0.00192	0.00238	CcSEcCtD
Mupirocin—Nausea—Captopril—systemic scleroderma	0.00191	0.00238	CcSEcCtD
Mupirocin—Haemorrhage—Prednisone—systemic scleroderma	0.00191	0.00237	CcSEcCtD
Mupirocin—Pruritus—Leflunomide—systemic scleroderma	0.00188	0.00233	CcSEcCtD
Mupirocin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00187	0.00232	CcSEcCtD
Mupirocin—Dizziness—Azathioprine—systemic scleroderma	0.00186	0.00231	CcSEcCtD
Mupirocin—Diarrhoea—Leflunomide—systemic scleroderma	0.00182	0.00226	CcSEcCtD
Mupirocin—Urticaria—Lisinopril—systemic scleroderma	0.00181	0.00225	CcSEcCtD
Mupirocin—Abdominal pain—Lisinopril—systemic scleroderma	0.0018	0.00224	CcSEcCtD
Mupirocin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00179	0.00223	CcSEcCtD
Mupirocin—Rash—Azathioprine—systemic scleroderma	0.00177	0.0022	CcSEcCtD
Mupirocin—Dermatitis—Azathioprine—systemic scleroderma	0.00177	0.0022	CcSEcCtD
Mupirocin—Headache—Azathioprine—systemic scleroderma	0.00176	0.00219	CcSEcCtD
Mupirocin—Dizziness—Leflunomide—systemic scleroderma	0.00176	0.00218	CcSEcCtD
Mupirocin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00173	0.00215	CcSEcCtD
Mupirocin—Immune system disorder—Prednisone—systemic scleroderma	0.00172	0.00214	CcSEcCtD
Mupirocin—Pain—Mycophenolate mofetil—systemic scleroderma	0.00171	0.00212	CcSEcCtD
Mupirocin—Hypersensitivity—Lisinopril—systemic scleroderma	0.00168	0.00209	CcSEcCtD
Mupirocin—Dizziness—Mycophenolic acid—systemic scleroderma	0.00168	0.00208	CcSEcCtD
Mupirocin—Epistaxis—Methotrexate—systemic scleroderma	0.00168	0.00208	CcSEcCtD
Mupirocin—Rash—Leflunomide—systemic scleroderma	0.00167	0.00208	CcSEcCtD
Mupirocin—Dermatitis—Leflunomide—systemic scleroderma	0.00167	0.00208	CcSEcCtD
Mupirocin—Nausea—Azathioprine—systemic scleroderma	0.00167	0.00208	CcSEcCtD
Mupirocin—Headache—Leflunomide—systemic scleroderma	0.00166	0.00207	CcSEcCtD
Mupirocin—Erythema—Prednisone—systemic scleroderma	0.00166	0.00206	CcSEcCtD
Mupirocin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00163	0.00203	CcSEcCtD
Mupirocin—Pruritus—Lisinopril—systemic scleroderma	0.00161	0.00201	CcSEcCtD
Mupirocin—Haemoglobin—Methotrexate—systemic scleroderma	0.0016	0.00199	CcSEcCtD
Mupirocin—Rash—Mycophenolic acid—systemic scleroderma	0.0016	0.00198	CcSEcCtD
Mupirocin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0016	0.00198	CcSEcCtD
Mupirocin—Haemorrhage—Methotrexate—systemic scleroderma	0.00159	0.00198	CcSEcCtD
Mupirocin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00197	CcSEcCtD
Mupirocin—Headache—Mycophenolic acid—systemic scleroderma	0.00159	0.00197	CcSEcCtD
Mupirocin—Pharyngitis—Methotrexate—systemic scleroderma	0.00158	0.00197	CcSEcCtD
Mupirocin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00196	CcSEcCtD
Mupirocin—Nausea—Leflunomide—systemic scleroderma	0.00158	0.00196	CcSEcCtD
Mupirocin—Diarrhoea—Lisinopril—systemic scleroderma	0.00156	0.00194	CcSEcCtD
Mupirocin—Angioedema—Prednisone—systemic scleroderma	0.00152	0.00189	CcSEcCtD
Mupirocin—Dizziness—Lisinopril—systemic scleroderma	0.00151	0.00187	CcSEcCtD
Mupirocin—Nausea—Mycophenolic acid—systemic scleroderma	0.0015	0.00187	CcSEcCtD
Mupirocin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00183	CcSEcCtD
Mupirocin—Immune system disorder—Methotrexate—systemic scleroderma	0.00144	0.00179	CcSEcCtD
Mupirocin—Rash—Lisinopril—systemic scleroderma	0.00144	0.00179	CcSEcCtD
Mupirocin—Dermatitis—Lisinopril—systemic scleroderma	0.00144	0.00179	CcSEcCtD
Mupirocin—Headache—Lisinopril—systemic scleroderma	0.00143	0.00178	CcSEcCtD
Mupirocin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00176	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.0014	0.00174	CcSEcCtD
Mupirocin—Erythema—Methotrexate—systemic scleroderma	0.00139	0.00172	CcSEcCtD
Mupirocin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00137	0.0017	CcSEcCtD
Mupirocin—Dysgeusia—Methotrexate—systemic scleroderma	0.00136	0.00169	CcSEcCtD
Mupirocin—Nausea—Lisinopril—systemic scleroderma	0.00136	0.00168	CcSEcCtD
Mupirocin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00136	0.00168	CcSEcCtD
Mupirocin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00132	0.00164	CcSEcCtD
Mupirocin—Skin disorder—Prednisone—systemic scleroderma	0.00132	0.00164	CcSEcCtD
Mupirocin—Rash—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00157	CcSEcCtD
Mupirocin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00156	CcSEcCtD
Mupirocin—Headache—Mycophenolate mofetil—systemic scleroderma	0.00125	0.00156	CcSEcCtD
Mupirocin—Cough—Methotrexate—systemic scleroderma	0.00121	0.0015	CcSEcCtD
Mupirocin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00148	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00117	0.00146	CcSEcCtD
Mupirocin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00113	0.00141	CcSEcCtD
Mupirocin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00111	0.00138	CcSEcCtD
Mupirocin—Skin disorder—Methotrexate—systemic scleroderma	0.0011	0.00137	CcSEcCtD
Mupirocin—Urticaria—Prednisone—systemic scleroderma	0.00108	0.00134	CcSEcCtD
Mupirocin—Abdominal pain—Prednisone—systemic scleroderma	0.00107	0.00133	CcSEcCtD
Mupirocin—Hypersensitivity—Prednisone—systemic scleroderma	0.000999	0.00124	CcSEcCtD
Mupirocin—Pain—Methotrexate—systemic scleroderma	0.000969	0.0012	CcSEcCtD
Mupirocin—Pruritus—Prednisone—systemic scleroderma	0.000959	0.00119	CcSEcCtD
Mupirocin—Diarrhoea—Prednisone—systemic scleroderma	0.000927	0.00115	CcSEcCtD
Mupirocin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000926	0.00115	CcSEcCtD
Mupirocin—Urticaria—Methotrexate—systemic scleroderma	0.0009	0.00112	CcSEcCtD
Mupirocin—Dizziness—Prednisone—systemic scleroderma	0.000896	0.00111	CcSEcCtD
Mupirocin—Abdominal pain—Methotrexate—systemic scleroderma	0.000895	0.00111	CcSEcCtD
Mupirocin—Rash—Prednisone—systemic scleroderma	0.000855	0.00106	CcSEcCtD
Mupirocin—Dermatitis—Prednisone—systemic scleroderma	0.000854	0.00106	CcSEcCtD
Mupirocin—Headache—Prednisone—systemic scleroderma	0.000849	0.00105	CcSEcCtD
Mupirocin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000835	0.00104	CcSEcCtD
Mupirocin—Nausea—Prednisone—systemic scleroderma	0.000805	0.001	CcSEcCtD
Mupirocin—Pruritus—Methotrexate—systemic scleroderma	0.000801	0.000996	CcSEcCtD
Mupirocin—Diarrhoea—Methotrexate—systemic scleroderma	0.000775	0.000963	CcSEcCtD
Mupirocin—Dizziness—Methotrexate—systemic scleroderma	0.000749	0.000931	CcSEcCtD
Mupirocin—Rash—Methotrexate—systemic scleroderma	0.000714	0.000887	CcSEcCtD
Mupirocin—Dermatitis—Methotrexate—systemic scleroderma	0.000714	0.000887	CcSEcCtD
Mupirocin—Headache—Methotrexate—systemic scleroderma	0.00071	0.000882	CcSEcCtD
Mupirocin—Nausea—Methotrexate—systemic scleroderma	0.000673	0.000836	CcSEcCtD
